​

Praxis Precision Medicines (PRAX) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChartTranscripts

PRAX Stock Forecast

Praxis Precision Medicines (PRAX) stock forecast, based on 16 Wall Street analysts, predicts a 12-month average price target of $510.40, with a high of $843.00 and a low of $83.00. This represents a 68.24% increase from the last price of $303.37.

- $170 $340 $510 $680 $850 High: $843 Avg: $510.4 Low: $83 Last Closed Price: $303.37

PRAX Stock Rating

Praxis Precision Medicines stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (75.00%), 3 Hold (18.75%), 1 Sell (6.25%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 1 3 12 Strong Sell Sell Hold Buy Strong Buy

PRAX Price Target Upside V Benchmarks

TypeNameUpside
StockPraxis Precision Medicines68.24%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts51232
Avg Price Target$470.00$562.08$437.66
Last Closing Price$303.37$303.37$303.37
Upside/Downside54.93%85.28%44.27%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 2621311-17
Feb, 2621211-16
Jan, 26212-1-15
Dec, 25212-1-15
Nov, 25310-1-14
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 23, 2026Wolfe Research$500.00$342.4646.00%64.82%
Feb 20, 2026Truist Financial$700.00$342.65104.29%130.74%
Feb 20, 2026Deutsche Bank$412.00$331.6124.24%35.81%
Feb 20, 2026Robert W. Baird$433.00$331.6130.58%42.73%
Feb 20, 2026Wells Fargo$305.00$331.61-8.02%0.54%
Feb 10, 2026Guggenheim$800.00$319.54150.36%163.70%
Feb 04, 2026Needham$510.00$310.5264.24%68.11%
Feb 02, 2026Wells Fargo$282.00$314.00-10.19%-7.04%
Jan 05, 2026Ami FadiaNeedham$460.00$286.4060.61%51.63%
Dec 29, 2025BTIG$843.00$268.95213.44%177.88%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 09, 2026BTIGBuyBuyhold
Feb 23, 2026Wolfe ResearchOutperforminitialise
Feb 20, 2026WedbushUnderperformUnderperformhold
Feb 20, 2026Deutsche BankBuyBuyhold
Feb 10, 2026GuggenheimBuyBuyhold
Feb 04, 2026NeedhamBuyBuyhold
Jan 30, 2026H.C. WainwrightBuyBuyhold
Jan 29, 2026Cowen & Co.BuyBuyhold
Jan 28, 2026Piper SandlerOverweightOverweighthold
Jan 12, 2026WedbushUnderperformUnderperformhold

Financial Forecast

EPS Forecast

$-25 $-20 $-15 $-10 $-5 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.69$-10.21$-13.48---
Avg Forecast$-20.43$-10.20$-11.47$-11.46$-9.52$-2.37
High Forecast$-14.03$-10.07$-8.88$-6.61$-3.02$-1.09
Low Forecast$-24.96$-10.32$-13.94$-19.33$-17.04$-3.75
Surprise %-8.52%0.10%17.52%---

Revenue Forecast

$0 $90M $180M $270M $360M $450M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.45M$8.55M----
Avg Forecast$1.90M$1.47M$967.30K$31.98M$101.46M$308.29M
High Forecast$2.14M$1.83M$1.40M$46.35M$147.04M$446.80M
Low Forecast$1.82M$1.09M$565.43K$18.70M$59.31M$180.21M
Surprise %28.79%483.42%----

Net Income Forecast

$-350M $-280M $-210M $-140M $-70M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-123.28M$-182.82M$-303.27M---
Avg Forecast$-123.28M$-67.22M$-75.24M$-85.53M$-66.14M$-15.63M
High Forecast$-92.52M$-66.40M$-58.53M$-43.59M$-19.92M$-7.19M
Low Forecast$-164.62M$-68.04M$-91.95M$-127.47M$-112.35M$-24.76M
Surprise %-171.96%303.07%---

PRAX Forecast FAQ

Is Praxis Precision Medicines stock a buy?

Praxis Precision Medicines stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Praxis Precision Medicines is a favorable investment for most analysts.

What is Praxis Precision Medicines's price target?

Praxis Precision Medicines's price target, set by 16 Wall Street analysts, averages $510.4 over the next 12 months. The price target range spans from $83 at the low end to $843 at the high end, suggesting a potential 68.24% change from the previous closing price of $303.37.

How does Praxis Precision Medicines stock forecast compare to its benchmarks?

Praxis Precision Medicines's stock forecast shows a 68.24% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Praxis Precision Medicines over the past three months?

  • March 2026: 11.76% Strong Buy, 76.47% Buy, 5.88% Hold, 5.88% Sell, 0% Strong Sell.
  • February 2026: 12.50% Strong Buy, 75.00% Buy, 6.25% Hold, 6.25% Sell, 0% Strong Sell.
  • January 2026: 13.33% Strong Buy, 80.00% Buy, 0% Hold, 6.67% Sell, 0% Strong Sell.

What is Praxis Precision Medicines’s EPS forecast?

Praxis Precision Medicines's average annual EPS forecast for its fiscal year ending in December 2026 is $-11.46, marking a -14.99% decrease from the reported $-13.48 in 2025. Estimates for the following years are $-9.52 in 2027, and $-2.37 in 2028.

What is Praxis Precision Medicines’s revenue forecast?

Praxis Precision Medicines's average annual revenue forecast for its fiscal year ending in December 2026 is $31.98M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $101.46M, and $308.29M for 2028.

What is Praxis Precision Medicines’s net income forecast?

Praxis Precision Medicines's net income forecast for the fiscal year ending in December 2026 stands at $-85.528M, representing a -71.80% decrease from the reported $-303M in 2025. Projections indicate $-66.138M in 2027, and $-15.629M in 2028.